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Abstract The trade-off between resolution and count sensitivity
dominates the performance of standard gamma cameras and dic-
tates the need for relatively high doses of radioactivity of the used
radiopharmaceuticals in order to limit image acquisition dura-
tion. The introduction of cadmium-zinc-telluride (CZT)-based
cameras may overcome some of the limitations against
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conventional gamma cameras. CZT cameras used for the evalu-
ation of myocardial perfusion have been shown to have a higher
count sensitivity compared to conventional single photon emis-
sion computed tomography (SPECT) techniques. CZT image
quality is further improved by the development of a dedicated
three-dimensional iterative reconstruction algorithm, based on
maximum likelihood expectationmaximization (MLEM), which
corrects for the loss in spatial resolution due to line response
function of the collimator. All these innovations significantly
reduce imaging time and result in a lower patient’s radiation
exposure compared with standard SPECT. To guide current
and possible future users of the CZT technique for myocardial
perfusion imaging, the Cardiovascular Committee of the
European Association of Nuclear Medicine, starting from the
experience of its members, has decided to examine the current
literature regarding procedures and clinical data onCZTcameras.
The committee hereby aims 1) to identify the main acquisitions
protocols; 2) to evaluate the diagnostic and prognostic value of
CZT derived myocardial perfusion, and finally 3) to determine
the impact of CZT on radiation exposure.
Keywords Perfusion . CZTcamera . Coronary artery
disease . Diagnosis . Prognosis
Abbreviations
AC Attenuation correction
BMI Body mass index
CAD Coronary artery disease
CCTA Coronary CT angiography
CT Computed tomography
CZT Cadmium-zinc-telluride
EF Ejection fraction
ERNA Equilibrium radio nuclide acquisition
FBP Filtered back projection
FWHM Full-width at half-maximum
HMR Heart mediastinum ratio
i.v. Intravenous
LEHR Low-energy high-resolution (collimator)
LV Left ventricular
LVEF Left ventricular ejection fraction
MIBG meta-iodo-benzylguanidine
ML-EM Maximum likelihood expectation maximization
MPI Myocardial perfusion imaging
MRI Magnetic resonance imaging
MUGA Multi gated acquisition
OS-EM Ordered subsets expectation maximization
RV EF Right ventricular ejection fraction
SPECT Single photon emission computed tomography
QC Quality control
Design of the CZT cameras
Two semiconductor cadmium-zinc-telluride (CZT) cameras
are currently commercially available: the Discovery
NM530c camera (GE Healthcare, Haifa, Israel) (Fig. 1) and
the D-SPECT camera (Spectrum Dynamics, Biosensors,
Caesarea, Israel) (Fig. 2). Both cameras are relatively costly,
and, because of their limited field of view, are exclusively
conceived for myocardial imaging, restricting their use to cen-
ters with a high volume of activity in cardiology [1–4].
The two currently available cameras use the same type of
squared cadmium-zinc-telluride (CZT), but they have differ-
ent collimation and reconstruction algorithms. The D-SPECT
camera uses a system of rotational parallel-hole collimation
involving nine rotating detector columns equipped with a
wide-angle square-hole tungsten collimator [4]. This collima-
tor improves count sensitivity, when compared with conven-
tional low-energy high-resolution (LEHR) collimators. A high
spatial resolution is reached using a specific reconstruction
algorithm dealing with the particular geometry of the wide-
angle collimator [4, 5].
The design of the Discovery NM530c camera is different and
is based on a stationary multi-pinhole (i.e. n= 19) collimation
system [6]. Each pinhole has an effective aperture diameter of
only 5.1 mm that improves spatial resolution over count sensi-
tivity. High-count sensitivity is reached by the combined acqui-
sition of the heart area through the 19-pinhole detector blocks [6].
The heart-centric method of collimation of both techniques
most likely explains the enhanced count sensitivity, when com-
pared with conventional Anger cameras. In addition, iterative re-
construction methods, taking into account the collimation geom-
etry and limiting the noise level, have further improved image
quality [6–8]. However, the main factor leading to improved im-
age quality is a dramatic increase in energy resolution (Fig. 3) [9].
Within the CZT detector, the interaction of a 140 keV gam-
ma photon produces approximately 30,000 electrons, 20-fold
more than that produced by a NaI(Tl) crystal [9]. The most
significant consequence is that energy resolution is improved
by a factor of 2, compared with conventional Anger cameras.
In addition, this leads to marked improvements for dual iso-
tope recordings such as those involving 201Tl and 99mTc-la-
belled tracers [10, 11].
In all previously published studies, the interdependent pa-
rameters of spatial resolution and contrast-to-noise ratio were
consistently found to be markedly higher on CZT than on
conventional Anger cameras, on both phantom and human
images [6–9, 11]. Although a little controversial, these param-
eters appear to be slightly higher with the Discovery camera
than with the D-SPECT [6, 8, 12]. It is, however, very unlikely
that those small differences may have a significant impact on
the diagnostic accuracies of the two CZT cameras. When
using routine reconstruction parameters, the full width at half
maximum of a point source at the center of field of view is
Eur J Nucl Med Mol Imaging
only slightly lower with the Discovery (6.7 mm) than with the
D-SPECT (8.6mm) [6]. By contrast, the corresponding values
are worse with conventional Anger-SPECT, even with an as-
tigmatic collimator (15 mm for the IQ-SPECTsystem [6, 13]).
The tomographic count sensitivity is an additional critical
parameter influencing both the acquisition time and the
tracer’s activity needing to be injected. This sensitivity is rath-
er low on current SPECT-cameras, with only a fraction (10−6)
of the injected activities being detected within the myocardial
area [6, 14]. On Anger cameras, this fraction may be increased
using a collimator with convergent geometry. For instance,
count sensitivity is enhanced by a factor of 2 using the IQ-
SPECT technology instead of a conventional LEHR collima-
tor [6]. However, this increase is much more for the CZT
camera equipped with heart-centric collimators: threefold to
fourfold higher than on conventional Anger cameras for the
Discovery NM530c camera, and sevenfold to eightfold higher
for the D-SPECTcamera [6]. In this particular setting of count
sensitivity, it is likely that the wide-angle parallel hole system
of the D-SPECTcamera is superior compared with the pinhole
system of the Discovery NM 530c.
Acquisition protocols for CZT camera
99mTc perfusion agents and protocols
Two 99mTc-labelled perfusion tracers are available commer-
cially: 99mTc-2-methoxyisobutylisonitrile (MIBI) and 99mTc-
1,2-bis [bis(2-ethoxyethyl) phosphino] ethane (Tetrofosmin).
The activity to administer is a compromise among available
time, required image quality and the lowest reasonably
achievable radiation exposure to the patient and staff [15]
(Figs. 4 and 5).
Table 1 shows scanning parameters for single-day stress-rest
protocol on a CZT camera with 99mTc-labelled perfusion
tracers.
The injected doses should be chosen in order to reach a
count level (it is 0.5 to 1 million of counts for the D-SPECT,
and presumably in the same range for the Discovery, but this
may change according to the reconstruction and filtering pro-
cess). According to body weight or BMI (a twofold higher dose
is required for 120 than for 60 kg body weight) and to the mean
recording time, the targeted count level (a twofold higher dose
is required if you want to shorten the recording time from 12 to
6 min or from 12 to 6 min) can be reached. In this way, it is
really possible to choose a protocol: between the ones with very
low dose but longer recording time, and the ones with very
short recording times but much higher injected doses.
Several studies have described the role of CZTcameras in
myocardial perfusion imagingwith 99mTcagents.Most of the
studies used G.E. Discovery 530 NMc [16–22] or G.E.
Discovery 570 NMc [23, 24], while a few studies used D-
SPECT cameras [25–28]. Among studies using Discovery
530NMc cameras, most of them performed 1-day protocols,
except the protocol byGiorgetti et al. (2-day stress/rest) [18].
Among studies using D-SPECTcameras, three used a 1-day
protocol; only Verger et al. used 1-day protocol or 2-day
protocol [23].
In a study by Duvall et al. [16], three different protocols
were used (low-dose stress only, high-dose stress only, low-
dose rest with high dose stress). Oddstig et al. [20] examined,
different administered activities (4, 3 and 2.5 MBq/Kg stress,
respectively) in three different groups of coronary artery dis-
ease (CAD) patients. Similar examinations have been per-
formed by Verger et al. [23] and Sharir et al. [29] on D-
SPECT cameras. Results of most studies suggest that CZT
cameras are able to reduce acquisition time, administered ac-
tivity and dose to patients, with an excellent image qualityFig. 2 CZT camera by D-SPECT
Fig. 1 CZT camera by Ge (NM530c)
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score [30]. In the study by Herzog et al. [31], minimum scan
times of 3 min for low-dose and 2 min for high-dose scans
were suggested. Nevertheless, in a study by van Dijk et al.
[28], CZT SPECT image quality like that in conventional
cameras decreased with weight, so that for CZT cameras,
weight-adjusted doses might also be required to achieve an
optimal image quality.
Dual isotope imaging
Dual perfusion imaging
Because of the geometry of detection and focused acquisition,
the ratio between acquired 201Tl myocardial counts and total
acquired counts is better with CZT cameras, approximately
0.35 to 0.50 versus 0.15 to 0.20 with Anger cameras [31–33].
The published studies conclude that with CZT cameras and
201Tl, acquisition times can be reduced down to 4–6 min or
injected activities decreased down to 0.7 MBq/kg with high
quality images [33].
Dual isotope simultaneous (201Tl and 99mTc-labelled
tracers) perfusion imaging represents an attractive approach,
since it might allow to acquire simultaneously in one SPECT
acquisition the distribution of myocardial perfusion at stress
and at rest, and avoid co-registration issues associated with
separate sets of images. The poor energy resolution of con-
ventional cameras has precluded its utilisation so far.
The unique possibility offered by gamma emitters to com-
bine 201Tl and 99mTc-labelled tracers to assess separate func-
tions was investigated long ago. As expected, the crosstalk of
99mTc down-scatter in 201Tl energy window strongly ham-
pered the image quality in the simultaneous approach.
Thanks to the improved energy resolution of CZT cameras,
the opportunity of simultaneous 201Tl/99mTc acquisitions has
been reconsidered.
Initial clinical validation of dual-isotope acquisitions with a
CZT camera used a sequential stress 201Tl /rest 99mTc protocol
[10]. The overall duration of the procedure, including two stress
(supine and sitting positions) and a rest acquisition, was about
20 min and the mean effective dose was 12 mSv. The compar-
ison of the 201Tl /99mTc protocol with the standard 99mTc /99mTc
showed similar image quality, normalcy rates and dosimetry.
More recently, further evidence of the diagnostic value of a
similar sequential dual-isotope protocol has been reported with
reference to coronary angiography in CAD patients at interme-
diate to high-risk of CAD [34]. In summary, all studies show that
sequential dual-isotope acquisitions on CZT cameras allow for
reduction of the total length of the diagnostic procedure while
keeping radiation dose at a similar level as single 99mTc proto-
cols on conventional cameras [10, 11, 34].
Fig. 3 Energy resolution on CZT
camera
3 MBq/kg of 99mTc 
perfusion agent
9 MBq/kg of 99mTc
perfusion agent
Gated Stress 
perfusion scan
~ 8 min*
Gated Rest 
perfusion scan
~ 4 min*
*Perfusion imaging times may differ depending on patient BMI. 
Delay 
2 H
Stress test Delay 
1 H
Delay 
10 min
Fig. 4 Stress- rest myocardial
perfusion imaging (MPI) using
99mTc perfusion agent and D-
SPECT camera in routine
(University Hospital of Caen,
France). If stress scan is normal,
rest scan is not mandatory. (BMI
= Body Mass Index)
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The alternative approach of simultaneous dual isotope ac-
quisitions has been reported by Ben-Haim et al. in a series of 24
patients with a history of coronary artery disease [11]. The
authors compared a sequential acquisition on a conventional
camera (rest 201Tl / stress 99mTc) with a single 15-minute list-
mode acquisition on the D-SPECT. The correlation of summed
scores between the two protocols was good, as well as the
concordance of vascular territory with perfusion abnormalities.
Despite the limitations of the study related to the rather high
injected doses to fit with the requirement of the conventional
camera, and the small sample size, this study proved the feasi-
bility of simultaneous 201Tl /99mTc acquisitions in humans.
However, the overall duration of the protocol was not reduced
compared with sequential protocols.
Dual perfusion-innervation imaging
Sequential 123I-MIBG/ 99mTc-tetrofosmin acquisition on a
CZT camera has been first reported by the GE Discovery
system [35]. In this study, 28 patients underwent early and
delayed planar and CZT acquisitions with 123I-MIBG, then
99mTc-tetrofosmin was injected and a last CZT acquisition
was performed on the 99mTc energywindow and reconstructed
using an algorithm that did not include scatter correction.
Heart-to-mediastinum ratio (HMR) was calculated from pla-
nar acquisitions, whereas summed scores were derived from
tomographic acquisitions performed on the CZT. Overall, the
authors found that early regional adrenergic innervation het-
erogeneity correlatedwith abnormal myocardial perfusion and
contractile function. This study proved the feasibility of the
combined evaluation of innervation and perfusion with a
99mTc-labelled tracer in a 1-day protocol on a CZT camera.
Recently, Bellevre et al. [36] reported on simultaneous dual
123I-MIBG / 99mTc-tetrofosmin acquisitions with the D-
SPECT system in the determination of the HMR (4 hours
post-injection), comparative to 123I-MIBG alone on a conven-
tional camera and LEHR collimation. A planar equivalent
image of the thorax was reconstructed by summing individual
planar projections of each detector. ROIs were then deter-
mined manually on the 99mTc-tetrofosmin image, and auto-
matically applied on the 123I-MIBG image. In order to correct
for the different contribution of scatter between the two cam-
eras, a correction factor derived from a prior anthropomorphic
torso phantom study was applied. In a population of 44 pa-
tients, the authors found a very good agreement in HMR
values between the conventional cameras and the corrected
Table 1 Scanning parameters for
single-day stress-rest protocol on
a CZT camera (Ge or DPS cam-
era) with 99mTc-labeled tracers
Feature Stress Rest Technique
Dose 3–5 MBq/kg 9–15 MBq/kg Preferred
Position
Supine Standard with Ge camera
Prone Optional
Upright or semi-upright Standard with D-SPECT camera
Preferred in obese patient
Delay time
Injection to imaging 10–60 min 30–60 min Standard
Stress to rest 30 min to 4 h Standard
Energy window Standard
Acquisition time 4–10 min 2–6 min Preferred
ECG gated Standard Standard Standard
Frames/cycle 16 16 Standard
R-to-R window (for LV EF) 100 % 100 % Preferred
Attenuation correction Measured AC
before or after
SPECT scan
Measured AC
before or after
SPECT scan
Optional (only with Ge camera)
Fig. 5 MPI showing a good concordance between Anger camera (top
panel) and D-SPECTcamera (bottom panel) in patient with BMI < 30 UI
and myocardial infarction. MPI illustrates infarction in the antero-apical,
antero-medial, septal and apical myocardial regions. (University Hospital
of Nancy, France)
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values obtained with the D-SPECT. The standardization of
HMR as recommended by Nakajima et al. [37] when using
simultaneous dual 123I-MIBG / 99mTc-labelled perfusion trac-
er on CZT cameras still needs to be evaluated in a larger
population of cardiomyopathy.
Diagnostic Performances and Prognostic value
of MPI with CZT cameras
Diagnostic value of MPI
MPI acquired with CZT SPECT has, compared to the images
from conventional SPECT, an improved image quality but
comparable diagnostic confidence (Fig. 4). Two studies have
compared the performance of conventional SPECT MPI and
CZT SPECTMPI. Gimelli et al. [38] have demonstrated in 34
patients with known CAD or high CAD likelihood (85 %
prevalence of obstructive CAD, > 70 % stenosis), who
underwent coronary angiography by CT or invasive coronary
angiography, that CZT SPECT was superior to conventional
SPECT for detecting global and regional ischemia, and iden-
tified a higher number of vessels with obstructive CAD. ROC
area for CZT SPECT was significantly higher than for con-
ventional SPECT (98 % vs. 86 %), and in 20 patients with
multi-vessel disease, CZT SPECT correctly identified 17,
compared to only six on conventional SPECT. In a multi-
center study, Neill et al. [24] assessed 50 patients who
underwent invasive coronary angiography (74 % prevalence
of obstructive CAD, > 50 % stenosis) and reported similar
results. CZT SPECT had superior sensitivity, specificity and
accuracy compared to conventional SPECT (92 %, 83 % and
90 % for CZT SPECT vs. 84 %, 50 % and 76 % for conven-
tional SPECT). Further studies in larger patient cohorts have
assessed the diagnostic accuracy of CZT SPECT alone with
sensitivity and specificity ranging from 84 to 95 % and 37 to
93 %, respectively [39–43].
In obese patients imaged on the CZT camera with multi-
pinhole collimation [44, 45], CT can be used for attenuation
correction, or supine and prone imaging can be performed,
providing better image quality and a sensitivity of 92 % and
a specificity of 67 %. Another previous study on the same
camera reported poor diagnostic quality in morbidly obese
patients with 81 % non-diagnostic studies, reduced to 55 %
when CT-based attenuation correction was performed, likely
due to difficulties in positioning morbidly obese patients in
this system. CZT SPECTwith parallel-hole collimation could
be performed in supine, upright and prone positions with im-
proved sensitivity, specificity and normalcy rates when two
sets of images (supine and upright) were used for analysing
potential attenuation artefacts.
Fiechter et al. [46] evaluated the impact of increased body
mass index on the quality of myocardial perfusion imaging
using NM/CT 570c-Ge in 81 patients with high (> 40 UI) or
very high (> 45 UI) BMI. They concluded that patients with
BMI > 40 UI should be scheduled for MPI on a conventional
SPECT camera, as it was difficult to obtain diagnostic image
quality on CZT cameras. The attenuation correction by CT
could not improve the image quality. However, Ben Haim
et al. [47] assessed whether additional upright imaging in-
creased the confidence of interpretation of stress only supine
MPI in 101 obese patients. They concluded that supine stress
MPI was inadequate in obese patients. The addition of upright
imaging significantly increased the ability to interpret scans as
diagnostic and might reduce considerably the need for rest
imaging.
Recently, Mouden et al. [26] have assessed the concordance
of CZT SPECTand fractional flow reserve (FFR), obtained from
invasive coronary angiography, a well-established invasive tool
for the assessment of the functional significance of coronary
stenoses. FFR plays a major role in patient selection for revascu-
larization,mainly in patientswith intermediate stenosis; however,
it currently can only be provided invasively. FFR measurements
were performed in 100 patients with stable angina and with
intermediate coronary stenosis (40–80 %) on invasive coronary
angiography. Thirty-one percent of patients had ischemia on
CZT SPECT (FFR 0.44–0.99, mean 0.83) and 20 patients had
ischemia on FFR (FFR< 0.75). The concordance per-vessel be-
tween CZT SPECT and FFR was 79 %. There were 27 patients
with discordant findings; seven had serial stenoses and 20 had a
focal stenosis. Discordance was most often due to abnormal
SPECT but normal FFR, and the 19 false-positive CZT
SPECT results occurred in patients with high BMI.
Finally, Caobelli et al. [48] evaluated CT based attenuation
correction (AC) to improve the accuracy of MPI by CZT (Ge
Discovery 530c) in 60 patients. AC with a co-registered ex-
ternal CT was feasible using CZT cameras and improved di-
agnostic accuracy mostly by improving specificity over un-
corrected images in all coronary arteries territories.
Prognostic value of normal MPI with CZT cameras
Oldan et al. [21] analyzed data on 2,088 patients (57 % CZT,
43 % Anger) who underwent MPI at the single institution for
clinical purposes. Perfusion defect size and extent of ischemia
were associated with outcomes (death and myocardial infarc-
tion), with no difference between the two camera systems and
no interaction between camera type, imaging variables, and
outcomes.
Einstein et al. [49] studied 100 patients presenting to the
emergency department with chest pain and who underwent
stress-first MPI scan. Patients were contacted at 3 months after
their MPI, and electronic records were assessed to evaluate the
need for reevaluation for chest pain. This single-center study
showed that the prognosis associated with normalMPI using a
low-dose, stress-first protocol on CZTcamera had an excellent
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short-term prognosis with a radiation effective dose averaging
0.99 mSv.
Yokota et al. [50] determined the prognostic value of normal
stress-only MPI with a comparison between conventional and
CZT-based SPECT in 1,650 consecutive patients without
CAD. After a median follow-up of 37 months, the incidence of
major cardiac events was 1.5%/year in patients with normalMPI
with the CZT cameras compared to 2 %/year in patients imaged
with conventional cameras (p = 0.08). De Lorenzo et al. [51]
evaluated the prognosis of 365 obese out of 1,396 patients fol-
lowing by telephone interview for the occurrence of all-cause
death, myocardial infarction and revascularization. The annual-
ized mortality rates were not significantly different among obese
and non-obese patients. Age, the use of pharmacologic stress and
an abnormal CZT-SPECT, but not obesity, were independent
predictors of death. In obese patients, single-day rest/stress
CZT-SPECT with a multipinhole camera provided prognostic
discrimination with high image quality.
LV volumes and EF measurements
Gimelli et al. [39] demonstrated that gated CZT acquired with
a super-fast protocol and standard doses resulted in high-
quality images and an equivalent level of CAD diagnostic
confidence. Moreover, the diagnostic accuracy of CZT was
significantly higher than that obtained with standard SPECT,
and similar volumes and ejection fractions were achieved.
There was also improved regional sensitivity in the identifica-
tion of diseased vessels, associated with a higher diagnostic
performance in patients with multivessel disease, a well-
known limitation of conventional SPECT [39]. These findings
have two possible explanations. The first is related to the
higher spatial resolution of ultra-fast SPECT leading to a bet-
ter delineation of myocardial walls. Second, the acquisition
can be focused on the heart and attenuation artefacts can be
reduced thank to rotational parallel-hole collimation.
As conventional SPECT, CZT can be used to evaluate not
only myocardial perfusion, but also cardiac function with a
low dose protocol, as recently validated against magnetic res-
onance imaging in the evaluation of LV volumes and systolic
function. Because of their higher spatial resolution, CZT cam-
eras enable an accurate evaluation of both LV regional wall
motion and global systolic function, allowing combined ac-
quisition of myocardial perfusion and contractile function.
Quantification of LVEF and regional function from the
Discovery NM530C system has been compared with cardiac
MRI in 60 patients with suspected CAD [52]. The authors
concluded that MPI using CZT SPECT cameras and quantita-
tive gated SPECT analysis accurately quantified LVEF, but
still underestimated LV volumes. Furthermore, segmental
wall motion and wall thickness analysis could be used to iden-
tify the extent of myocardial fibrotic scar.
Jensen et al. [53] estimate LVEF byMUGA and CZT in 82
patients scanned in the same sequential order on the three
cameras. Each acquisition was analyzed twice by two technol-
ogists. The lowest intra-observer and inter-observer variations
for LVEF measurements were observed using Na-I detectors
in planar or SPECT mode, whereas the best results were ob-
tained using the SPECT reconstruction acquired with CZT
camera. CZT SPECTcameramay thus offer to identify chang-
es in LVEF with greater certainty than using Na-I detector-
equipped systems.
To assess LVEF and LV volumes, Bailliez et al. [54, 55]
used the Amsterdam gated (AGATE) dynamic cardiac phan-
tom (Vanderwilt techniques, Boxtel, The Netherlands) to pro-
ceed 18 acquisitions on each CZT and Anger (IQ. SPECT)
camera. One hundred and twenty patients with low pretest
likelihood of coronary artery disease and normal stress perfu-
sion SPECTwere retrospectively analyzed to provide the nor-
mal limits for EDV, ESV, EF and regional function for each
cameramodel. They concluded that new CZTcameras yielded
different estimates of global LV function, which mainly varied
as a function of spatial resolution when assessed by 3D-edge
detection software like QGS. LV volumes were higher using
the DNM 530c compared to D-SPECT and IQ-SPECT, lead-
ing to decreased LVEF in normal subjects.
Impact of CZTon radiation exposure and acquisition
time
Patients’ effective doses of 14 mSv or higher are currently
reached with the injected doses recommended by the European
Society of Nuclear Medicine and conventional single-day proto-
cols on conventional cameras [15]. Several recent studies have
conducted a dose-reduction strategy with these highly sensitive
CZT cameras [16, 17, 22, 25] that led to reaching a mean effec-
tive dose that did not exceed 10 mSv, and down to a mean level
of 3.5 mSv [25]. This strategy is mainly based on the use of only
99mTc-labelled tracers (no single or dual protocol involving of
201Tl) and on a twofold to threefold averaged reduction in
injected doses, but further dose reductions in low risk popula-
tions, as well as in normal-weight subjects, seem feasible.
Firstly, indeed, a dramatic dose reduction may be achieved
in low- to mild-risk populations, thanks to an extensive use of
stress-first protocols where the normality of stress images may
avoid rest imaging. With conventional Anger cameras, a fre-
quent poor quality of the stress images limited the use of such
protocols, where the lower doses are injected at stress [23, 56,
57]. With the CZT cameras, such image quality problems may
be overcome, even in obese subjects [27]. Verger et al. [23]
showed a dose reduction related to the suppression of rest-
imaging account for around 30 % of injected doses in a stan-
dard population of patients referred to MPI on a CZT camera.
However, this reduction may be dramatically higher in low-risk
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populations with high rates of normal stress images [27]. At a
population scale, this leads to balancing the mean level of ra-
diation with that of cardiac risk, in line with the ALARA (BAs
LowAsReasonablyAchievable^) principle of dose adaptation.
Secondly, it is well known that the fraction of the injected
activity, which is detected within the heart area, is strongly
linked to the body weight and to the body mass index of pa-
tients [14]. As an example, for given injected doses and record-
ing times, the mean value of recorded myocardial activity will
be twofold higher in a population around 60 kg of body weight
than in another one around 120 kg. Therefore, according to the
ALARA principle, it is likely that the injected doses should be
adapted to body weight or to body mass index.
Recently, Einstein et al. [58] defined the eight best practices
from the 65 country IAEA Nuclear Cardiology protocols
Cross-Sectional Study (INCAPS) to significantly decrease
the radiation exposure. The maximal effective dose should
not exceed 15 mSv, 201Tl should be avoided for stress MPI
in patients younger than 70 years old, and the injected activity
should be limited at 130 MBq. This survey did not, however,
take into consideration the dose reduction strategies offered by
CZT cameras.
Limitations of CZT cameras
Allie et al. [59] reviewed technical, patient-related, and
operator-dependent pitfalls and artefacts specific to the D-
SPECT-dedicated cardiac camera, aiming to raise the awareness
of these factors and the need to limit them whenever possible.
These factors were divided into three categories: mechanical
(noisy module, absent module), patient related (motion, attenu-
ation, extra-cardiac uptake, infero-apical artefact) and operator
induced (extravasation-tissue injection, incorrect contours,
wrong scan pattern, wrong filter). The most glaring omissions
of the newCZTcameras are inferior detection ofmotion and the
lack of built-in attenuation correction. In practice, excessively
short imaging times with high-efficiency cameras prevent most
of the motion artefacts. If imaging time is only 3–5 min as
opposed to 15–25 min, there is little time for the patient to
move. The short imaging time increases imager alertness and
improves detection of patient motion. While CZT camera soft-
ware is suboptimal for detecting motion, one can often spot
patient motion after image processing as the short axes slices
become distorted. All the while re-imaging, if needed, is better
accepted by most patients, as only a few minutes are needed to
accomplish the task. Lack of true-attenuation correction with
CZT is a drawback, with no easy remedy in sight. Prone imag-
ing is a suboptimal substitute, possible in most patients but not
all. The addition of prone imaging also adds time to the proce-
dure, cutting down the efficiency advantage of the technology.
CT attenuation would add additional cost to an already high
purchase price.
Immobile patients are challenging for all imaging technol-
ogies. The smaller footprint high-efficiency cameras also
come with smaller tables, often making it difficult to safety
transfer and image immobile or infirm patients.
The lack of versatility of available CZT cameras (designed
for cardiac imaging only) is a deterrent for nuclear departments
with a low daily volume of cardiac studies, as the camera can-
not be employed for general nuclear medicine purposes. If
fewer than six to ten cardiac studies are done every day, there
would be prohibitive down-time for the expensive equipment.
Conclusion
The availability of CZT cameras for cardiac SPECT acquisi-
tions in US, Japan and Europe has allowed us to improve pa-
tient comfort, reduces imaging time, and radiation exposure to
patients. In the past 6 years, several studies have demonstrated
that CZT cameras can provide a reliable non-invasive evalua-
tion of myocardial perfusion, LV volumes and LVEF in CAD
patients. One important limitation for a wider use of CZT cam-
eras in nuclear medicine departments is the price of the cam-
eras, mainly applicable in cardiology with the need for high
patient throughput to be cost effective. European guidelines
on myocardial perfusion imaging using CZT cameras will be
needed when normal databases and LV EF are established in
different populations of patients with coronary artery disease.
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